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1. Introduction 
The oral cavity is the most predominant location in the head and neck region for primary 
malignant tumors, and more than 90 % cancer consists of squamous cell carcinoma 
(SCC).(Shah and Patel 2003)  SCC has a high propensity to early and extensive lymph node 
metastases. Regarding cancer stage distribution at diagnosis, regional spread is more 
frequent in cancers of oral cavity and pharynx compared to other cancers, including such as 
prostate, breast, lung and bronchus, and colorectum (Figure 1).(Jemal et al. 2010)  Therefore, 
clinicians for cancers of the oral cavity and pharynx have to regard regional metastasis as 
most important. Advanced SCC of the oral cavity has regional metastasis frequently, and 
even in small tumors (T1 or T2) has a relatively high propensity of regional lymph node    
 
 
Fig. 1. Regional stage distribution of selected cancers, United States, 1999 to 2005. 
Source: Horner M, Ries L, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2006. 
Bethesda, MD: National Cancer Institute; 2009. 
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metastasis. The five-year relative survival rate of patients who present with tumors localized at 
the primary site without dissemination to regional lymph nodes is 82%.(SEER, Oral cancer 
statistics, http://seer.cancer.gov/statfacts/html/oralcav.html) On the other hand, once 
dissemination to regional lymph nodes takes place, the survival rate reduces to nearly 50%. 
Advancement of regional disease, such as extracapsular spread and multiple nodal metastases, 
has influenced survival.(Myers et al. 2001; Shaw et al. 2009) Clearly, the regional status is the 
most significant independent prognostic factor,(Okura 2002; Shah et al. 1993; Taniguchi and 
Okura 2003) and appropriate management of the cervical lymph nodes is essential for control of 
disease.(Ferlito et al. 2006)  In this chapter, we review the literature to ascertain whether elective 
neck dissection should be performed for cN0 neck or wait-and-see policy is safe and adequate.  
1.1 Treatment of clinical N0 (cN0) neck 
The management of neck disease in head and neck cancer, including oral cavity cancer, has 
been considered one of the most important aspects of treatment. When nodal metastases are 
present, nobody can deny the important effect of therapeutic neck dissection in the 
prognosis of head and neck cancer patients. However, the role of elective neck dissection 
has been a matter of discussion. Even the patients with clinically negative nodes (cN0) may 
still harbor occult metastasis, although advances in imaging techniques such as computed 
tomography, magnetic resonance, ultrasound sonography (US), and positron emission 




Fig. 2. Imagings of a patient with T2N0M0 SCC of the oral tongue.  
A, preoperative positron emission tomography; B, preoperative enhanced computer 
tomography; C, enhanced computer tomography two months after transoral excision of the 
tumor. Preoperative assessment shows no involved node in the neck (A, B). Note late 
cervical nodal metastasis in the right side of the neck (Level III, C).   
Table 1 shows the results of neck metastases and of each imaging study per patient with 
SCC of the oral tongue. CT had 70% accuracy, MRI had 74%, and US had 83% accuracy. 
Among the three image techniques US had the highest accuracy, although the accuracy was 
dependent on the observer. Our policy is essentially wait-and-see, and most of false-
negative nodes were detected within 12 months after the initial transoral excision. In this 
study of oral tongue 66 (69%) patients with cN0 neck received intraoral excison alone, and 
16 (17%) developed late lymph node metastases. The rate of occult metastases was 17% for 
SCC of the oral tongue and 21% for SCC of the oral cavity. Since the occult metastatic rate of 
head and neck cancer ranges from 17—50% (average, 28%) in the literature (Table 2), the 
optimal method of management of clinical N0 neck remains controversial.  
www.intechopen.com
 Management for the N0 Neck of SCC in the Oral Cavity 
 
115 
CT MRI US 
   - + - + - + 
Pathologically negative1 65 15 27 5 39 3 
Pathologically positive 
Therapeutic neck dissection 2 24 1 16 1 12 
Elective neck dissection 5 0 2 0 1 0 
Regional recurrence 16 1 7 0 6 2 
 Loco-regional recurrence 4 0 2 0 2 0 
Total 92 40 39 21 49 17 
Sensitivity 52% 62% 67% 
Specificity 81% 84% 93% 
Positive predictive value 63% 76% 82% 
Negative predictive value 74% 73% 83% 
Accuracy 70% 74% 83% 
Table 1. Image accuracy of nodal positivity in patients with SCC of the oral tongue. 
1Pathologically negative includes patients who performed intraoral excision alone with no 
regional recurrence; CT, computed tomography; MRI, magnetic resonance imaging; US, 
ultrasound sonography;  -, negative; +, positive. Number indicates patient number. 
The N0 neck can be treated electively or can be carefully observed (wait-and-see), and the 
decision can be made from each own clinical experience (Table 1). Randomized controlled 
trial (RCT) is desired to determine which is preferred, however RCT is not easy task. So far 
four RCTs of the small sample size had been performed. Vandenbrouck et al.(Vandenbrouck 
et al. 1980) demonstrated that the survival rates were similar between two treatment arms in 
75 patients with oral cavity cancer, whereas Fakih et al.(Fakih et al. 1989) (n = 70) and 
Klingerman et al.(Kligerman et al. 1994) (n = 67) found that elective neck dissection had 
significant benefit for patients with tumor thickness of more than 4 mm. In 2009, Yuen et 
al.(Yuen et al. 2009) demonstrated that disease-free survival was quite similar between two 
arms in 71 patients with SCC of the oral tongue. Thus, these four RCTs failed to impact on 
clinicians due to the inconsistency and small number of cases studied. In 1994 Weiss et 
al.(Weiss et al. 1994) created a decision tree analysis and demonstrated that when the 
probability of occult cervical metastasis is more than 20%, the neck should be electively 
treated. Since then a large number of studies(Dias et al. 2001; Ferlito et al. 2006; Greenberg et 
al. 2003; Haddadin et al. 1999; O'brien et al. 2000; Sano and Myers 2007; Wei et al. 2006) 
supported their recommendation and preferred elective treatment for N0 neck,(Andersen et 
al. 1996; Bourgier et al. 2005; Brazilian 1998; Byers et al. 1998; Dias et al. 2001; Ferlito et al. 
2006; Franceschi et al. 1993; Greenberg et al. 2003; Haddadin et al. 1999; Huang et al. 2008; 
Kaya et al. 2001; O'brien et al. 2000; Sano and Myers 2007; Wei et al. 2006; Yuen et al. 1997) 
because their occult metastatic rates were much higher than 20% (Table 2). Currently, the 
National Cancer Comprehensive Network’s adopted practice guidelines have recommended 
elective neck dissection for clinical N0 cancer of the oral cavity, oropharynx, hypopharynx 
and supraglottic larynx. (NCCN, 2011)  These guidelines apply to the performance of 
elective neck dissections as part of treatment of the primary tumor.  
Another reason of the preference for elective neck dissection is less morbidity of 
supraomoyhoid neck dissection (SOHND) compared to classical radical neck 
dissection.(Spiro et al. 1996)  For primary tumors in the oral cavity the regional lymph nodes 
at highest risk for early dissemination by metastatic cancer are limited to Levels I, II, and III 
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% of occult 
metastasis 
Neck treatment 
Ho, 1992 OT T1-2 28 42 obs 
Lim, 2004 OT T1-2 56 32 obs 
Goto, 2005 OT T1-2 88 26 obs, END 
Lim, 2006 OT T1-2 54 28 obs, SOHND 
Keski-Sӓntti, 2006 OT T1-2 80 30 obs, END 
Kligerman, 1994 OC T1-2 67 43 obs, SOHND 
Brazilian H&N, 1998 OC T2-4 148 28 mRND, SOHND 
Kaneko, 2002 OC T1-4 868 17 obs, END 
Amaral, 2004 OC T1-2 117 23 END 
Smith, 2004 OC T1-2 150 28 obs, END 
Zbӓren, 2006 OC T1-3 100 20 SOHND 
Clark, 2006 OC T1-4 105 34 obs, END 
Mathew lype, 2008 OC T1-4 219 27 SOHND 
Okura, 2009 OC T1-4 165 21 obs, END 
Kraus, 1996 OC, OP T1-4 44 32 SOHND 
Nieuwenhuis, 2001 OC, OP T1-2 161 21 obs 
Duvvuri, 2004 OC, OP T1-2 359 25 obs, END 
O'Brien, 2008 OC, OP T1-4 108 30 END 
Spiro, 1996 H&N - 268 25 SOHND 
van den Brekel, 1999 H&N T1-4 77 18 obs 
Coatesworth, 2002 H&N T1-4 63 30 END 
Gourin, 2008 H&N T1-4 337 50 END 
Total     3662 28   
Table 2. Analysis of occult metastasis. 
OT, oral tongue; OC, oral cavity; OP, oropharynx; H&N, head and neck; obs, observation; 
END, elective neck dissection; SOHND, supraomohyoid neck dissection; mRND, modified 
radical neck dissection. 
in the supraomohyoid triangle. Skip metastasis to Levels IV and V in the absence of 
metastatic disease at Levels I, II, or III is exceedingly rare.(Shah et al. 1993)  Compared to 
radical neck dissection SOHND reduces morbidity, including spinal accessory nerve 
disorder which results in diminished or absent function of the sternocleidomastoid muscle 
and upper portion of the trapezius muscle, and reduces cosmetic deformity.  In addition, 
SOHND is considered as effective as comprehensive procedures for staging the clinically 
negative neck, when the neck is treated electively. It is intrinsic in the philosophy of a 
preventive treatment, to make it the less morbidity possible without losing oncologic results. 
However, this elective policy results in overtreatment of the neck, when the neck actually 
has no involved nodes.  The less shoulder morbidity accompanied with SOHND is nonzero. 
Approximately 20% of patients who received SOHND had a shoulder pain even with 
conserving the accessary nerve.(Van Wilgen et al. 2004) Such overtreatment should be 
avoided when patients have no involved nodes in the neck.  
1.2 Decision tree analysis 
Upon returning decision tree analysis of Weiss et al., the decision tree is based on an analysis 
of the utility of the management options taking into account the incidence of node 
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involvement, complications of treatment, and disease control rates.(Weiss et al. 1994)  In 
sensitivity analysis they defined the expected utility to a function of the occult metastatic rate. 
They concluded that cN0 necks should be treated electively when the occult metastatic rate is 
more than 20%. The 20% of threshold has likely exerted a great influence on the management 
of cN0 necks, because they estimated curable probabilities using data of reviews published in 
the 1980s. Weiss et al. have however alluded that the values will change and the threshold will 
be altered with the times. The recommendation for elective neck dissection in more than two 
decades has to be reconsidered with the current data. Accordingly we have reconfigured the 
decision tree sensitivity analysis with our current disease control rates to determine optimal 
therapy based on a current set of underlying assumptions.(Okura et al. 2009)  Two decision 
tree strategies for the management of cN0 neck was compared; elective neck dissection or 
wait-and-see. In sensitivity analysis the expected utility for each strategy is a function of occult 
metastatic rate according to Weiss study. The higher utility value is preferable to the lower 
one, and the intersection indicates the treatment threshold.  
1.3 Formula of the threshold for the treatment of cN0 neck 
The treatment threshold between elective neck dissection and observation was estimated 
with three (a–c) probabilities of survival; a = the curable probability (5-year overall survival 
rate) of the patients received elective neck dissection with no neck recurrence, b = the 
curable probability of the observed patients with late neck metastasis, c = the curable 
probability of the observed patients with no neck recurrence. These three probabilities are 
different in each institution. With the sensitivity analysis, the treatment threshold (Rx) can 
be calculated through the following:  
Rx = (c − 0.97a) ⁄ (0.00376 − 0.0776a − 0.94b + c).  
When clinicians calculate their own 3 probabilities (a–c) of being cured, they can estimate their 
own threshold for treatment of cN0 neck using this formula. The formula will be put to 
practical use and will estimate the current threshold. Our calculated threshold of the occult 
rate between the two strategies was 44.4% (Table 3). In our practice a patient with SCC of the 
oral cavity and N0 neck should be carefully observed if the probability of occult cervical 
metastasis is less than 44.4%. Only if the probability is greater than 44.4%, elective neck 
dissection might be warranted. Since the probability c is the survival rate for patients with no 
involved nodes who do not have occult metastases, c is expected to be a high rate. The 
probability a is the survival rate for patients who received elective neck dissection and should 
be lower than c, because some have occult metastases.  If the occult metastatic rate is 0%, then 
the probability a would be quite same to c. A high occult metastatic rate and poor survival for 
patients with occult metastases contribute to a difference in probability between a and c.  
Table 3 shows the treatment threshold in various three probabilities according to the 
formula. For instance, assuming that c is fixed to 80% and a is 65% gives Rx more than 30% 
when b is not less than 20%. Rx becomes greater in proportion to the increase of b, because 
the denominator in the formula is decreased. Assuming that a is 70%, Rx is more than 22%. 
Assuming that the difference between a and c is 5% (a = 75%), Rx is 13% when b = 20% and 
16% when b = 30%, respectively. These Rx rates are too lower, however Rx goes up to more 
than 30% when b is more than 54%. Furthermore, providing that the difference between a 
and c is decreased to 2%, Rx is below 20% when b is less than 50%. For giving Rx > 30%, b 
needs more than 64%. It is therefore necessary for giving Rx high percentage to build up 
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high b probability as well as the positive difference between a and c. First, we have to raise 
the successful salvage rate for patients with late neck metastases. In Table 3 when b is more 
than 60%, Rx is invariably over 24%.  
 
a b c Rx  
60% 50% 60% 21% Weiss et al. 
87.8% 71.3% 94.5% 44.4% Okura et al. 
 
65% 20% 80% 30%  
65% 30% 80% 36%  
70% 20% 80% 22%  
70% 30% 80% 26%  
70% 40% 80% 32%  
70% 50% 80% 43%  
75% 20% 80% 13%  
75% 30% 80% 16%  
75% 40% 80% 20%  
75% 54% 80% 30%  
75% 60% 80% 40%  
78% 30% 80% 9%  
78% 40% 80% 12%  
78% 50% 80% 16%  
78% 60% 80% 24%  
78% 64% 80% 31%  
78% 70% 80% 51%  
Table 3. Three probabilities (a–c) and treatment threshold (Rx).  
Rx of our study (2009) was two times or more as high as that of Weiss study (1994). Rx is 
calculated with each a, b and c using the formula.  
1.4 Predictors of occult metastases 
The management of cN0 neck of SCC of the oral cavity is not necessarily wait-and-see 
(observation). In our study the overall occult rate was 21%, relatively low compared to other 
studies (Table 2) and our policy is wait-and-see. Notwithstanding, one-fifth of patients with 
cN0 neck need late neck dissection when all necks of those patients were observed. Patients 
with higher probability of occult metastases are encouraged to be selected with other 
predictors.  For instance, our occult metastatic rate was 14% for T1 lesions, 23% for T2 
lesions, and 30% for T3 lesions, respectively (Table 4).  
 
T stage Incidence Rate 
T1 21/152 14% 
T2 54/232 23% 
T3 16/53 30% 
T4 7/38 18% 
Total  98/475 21% 
Table 4. Incidence and rate of occult metastases according to T stage. 
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The rate is increased in proportion of the increase of T stage, except for T4.  The increase of 
primary lesions compels us to consider elective treatment, although the highest rate for T3 is 
still lower than our treatment threshold (44.4%). Other predictors of occult metastases are 
essential to management of cN0 necks.  
Numerous studies have reported that histologic tumor thickness correlates closely with 
lymph node metastases in SCC of the oral cavity.(Asakage et al. 1998; Byers et al. 1998; 
Fukano et al. 1997; Lim et al. 2004; O-Charoenrat et al. 2003; Spiro et al. 1986; Yamazaki et al. 
2004; Yuen et al. 2000)  Patients with more than 3 – 6 mm of histologic tumor thickness 
recommends to treated electively because of high risk of metastases. However accurate 
preoperative assessment of the thickness in biopsy section is no easy task. It is occasionally 
difficult to reach an invasive front on biopsy, and the tumor thickness on biopsy is not 
necessarily the greatest. In order to detect tumor thickness more accurately, sequential 
sections are desirable but not pragmatic. Accordingly, multi-sliced imaging techniques 
should be useful and convenient.  
Recently, the correlation between histologic tumor thickness and magnetic resonance 
imaging (MRI) tumor thickness was demonstrated (Iwai et al. 2002; Lam et al. 2004; Preda et 
al. 2006). Then MRI tumor thickness seems to become a candidate of occult metastatic 
predictor, although these studies did not reach to demonstrate the relation with MRI tumor 
thickness and regional metastases. We have verified MRI tumor thickness in patients with 
oral tongue SCC.(Okura et al. 2008)  Coronal MRI was preferred to measure tumor thickness 
than axial image (Figure 3).  
 
 
Fig. 3. Coronal contrasted-enhanced T1-weighted MRI shows tumor thickness (T) and 
paralingual distance (P). A vertical white line is a reference line connecting two tumor-
mucosa junctions. A horizontal white line drawn perpendicular to the reference line 
represents radiologically is tumor thickness (T). The image shows that a high-intensity area, 
paralingual spatium, extends from the medial border of the sublingual space to the deep 
lingual artery along the genioglossus. The white line (P) is the paralingual distance between 
the tumor and the paralingual spatium.   
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Eighty-one % MRI permitted us the measurement of tumor thickness, however the 
remaining 19% could not be interpreted because of the interference of artifacts. There are 
some patients unsuitable for MR scan. Notwithstanding, MRI tumor thickness was related 
to lymph node metastases, and the mean of tumor thickness in patients with nodal 
metastases was twice length of that without nodal metastases. The thicker tumor thickness 
is, the higher the probability of lymph node metastases is (Table 5). Using logistic regression 
model, MRI tumor thickness was able to predict nodal metastasis in SCC of the oral tongue. 
Multivariate logistic regression function showed that if tumor thickness was 9.7mm, then 
the probalility of metastases was 20%. Tongue cancer varies in the growth pattern, 
endophytic or exophytic. Even if tumor thickness is similar in size, the position of the 
invasive front is different between endophytic and exophytic tumors. In order to observe 
where tumor cells invade, the paralingual distance between the invasive front and the 
paralingual spatium of tongue was measured (Figure 3). The paralingual spatium is loose 
connective tissue, which locates between the genioglossus muscle and the intrinsic tongue 
muscles to sublingual space. Lingual nerve and lingual artery run through this spatium, and 
the lingual artery is the landmark of this spatium. The paraligual distance was significantly 
related to lymph node metastases. The probability of nodal metastasis was in inverse 
proportion to the paralingual distance, and the probability was 20% at 5.2 mm of 
paralingual distance (Table 5). The two MRI parameters were more reliable than 
preoperative assessment of clinical N staging because of the log likelihood ratio. In our 
practice, when MR tumor thickness is more than 9.7 mm or paralingual distance is less than 
5.2mm, we take elective neck dissection into consideration.  
 
Probability of lymph Tumor Paralingual 
node metastasis thickness distance 
(%) (mm) (mm) 
10% 7.1 6.5 
20% 9.7 5.2 
25% 10.6 4.7 
30% 11.5 4.3 
40% 12.9 3.6 
50% 14.2 3.0 
Table 5. Lymph node metastasis and measured MRI distances in SCC of the oral tongue. 
Entering 5.2 mm of paralingual distance into the cut-off point resulted in 82% of specificity, 
70% of sensitivity, and 14% of occult metastatic rate. The specificity of paralingual distance 
is higher than that using other images and the occult metastatic rate is the lowest (Table 1). 
Thus, MRI distances are useful to detect occult metastases of the oral tongue. Other 
endeavor to improve the accuracy of detecting occult metastases will be required.  
2. Survival 
In our study overall survival was similar, whether patients with cN0 neck are observed or 
electively treated.  The 5-year overall survival rate for observed patients was 89%, and the 
rate for patients received elective neck dissection was 86% (Figure 4).  On the other hand, 
patients with cN 1-3 neck had significantly lower overall survival (54% at 5-year) than those 
with cN0 neck.  
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Fig. 4. Overall survival according to clinical N stage.  
Clinical N0 necks were treated with two treatment arms: observation and elective neck 
dissection.  
The outcome depends on the extent of the occult metastases at the time they are detected, 
which correlates with the intensity of follow-up.(Cheng and Schmidt 2008)  In our practice, 
follow-up took place at every month in the first year, at two months in the second year, at 
three months in the third year, at four months in the fourth year, and 6 months in the fifth 
year. CT scan and ultrasound sonography were performed every half year. The follow-up is 
basic management, and the optional examinations are appended individually.  For instance, 
patients with higher risk of lymph node metastases have ultrasound examination more 
times, and patients with higher risk of distant metastases have positron emission 
tomography test or pulmonary CT scan. It is important to understand which risks are high. 
3. Conclusion  
At present, it is impossible to set the incidence of occult metastases to zero. Additionally, more 
sensitive parameters or markers associated with the presence of nodal metastasis are 
encouraged to be developed. The continued advancement will have a significant impact on the 
evaluation, management and outcome of patients with the oral cavity. For the current 
management for the cN0 neck, the important points are:  Clinicians have to comprehend their 
own threshold between observation and elective neck dissection. For that purpose, it is 
necessary to estimate the occult metastatic rate and three probabilities of survival (a, b, c). 
Then, the best policy of the management of cN0 necks is able to be controlled and determined.  
Extended operations with less morbidity in surgical oncology have been pursued to 
improve the outcomes. However, these extended operations are not necessarily wise. 
Recently, extended para-aortic nodal dissection did not improve the survival of patients 
with gastric cancer,(Sasako et al. 2008) and axillary lymph node dissection should be 
considered unnecessary for woman with T1-2 invasive breast cancer.(Giuliano et al. 2011)   
Thus, some extended operations do not seem to be the standard treatment.  
In SCC of the oral cavity, elective neck dissection does not also seem to be superior to a 
wait-and-see policy, and vice versa. Current studies, retrospective and prospective, have 
been unable to give us definitive recommendations regarding the management of the cN0 
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neck in those patients.  However, the cN0 necks might be conserved more frequently 
without the decline of survival by means of the improvement of nodal assessment and the 
higher salvage rate of late lymph node metastases. 
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